1. Home
  2. P vs IQV Comparison

P vs IQV Comparison

Compare P & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everpure Inc. Class A common stock

P

Everpure Inc. Class A common stock

HOLD

Current Price

$132.55

Market Cap

51.5B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$273.59

Market Cap

43.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
P
IQV
Founded
2009
1982
Country
United States
United States
Employees
N/A
93000
Industry
Electronic Components
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.5B
43.1B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
P
IQV
Price
$132.55
$273.59
Analyst Decision
Buy
Strong Buy
Analyst Count
20
21
Target Price
$151.11
★ $302.67
AVG Volume (30 Days)
★ 3.1M
1.0M
Earning Date
11-18-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.42
4.67
EPS
0.28
★ 1.61
Revenue
$3,662,843,000.00
★ $9,739,000,000.00
Revenue This Year
$38.00
$6.79
Revenue Next Year
$39.01
$6.06
P/E Ratio
$441.11
★ $172.91
Revenue Growth
15.61
★ 41.60
52 Week Low
$65.75
$154.50
52 Week High
$157.57
$282.98

Technical Indicators

Market Signals
Indicator
P
IQV
Relative Strength Index (RSI) 53.43 57.47
Support Level $90.96 $252.55
Resistance Level $157.57 $274.49
Average True Range (ATR) 7.58 7.84
MACD -3.29 1.06
Stochastic Oscillator 37.17 67.59

Price Performance

Historical Comparison
P
IQV

About P Everpure Inc. Class A common stock

Everpure Inc is a globalised technology company providing an integrated storage and data management platform. Data is foundational to customers' business transformation and increasingly central to their operational resilience and competitive differentiation. The company has evolved into a company that delivers a cloud experience with an intelligent, unified storage and data management platform (the Everpure Platform) that virtualizes data across on-premises, hybrid, and public cloud, and edge environments into a single storage layer with consistent control, built-in automation, and continuous modernization. Its business activities are a single operating and reportable segment. Operating in the USA and Rest of world, having maximum revenue in the USA.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: